Skip to content
10-K

Annual Report

INTEGRATED BIOPHARMA INC INBP

0001437749-25-029711

← back to feed
Filed
Sep 23, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Sep 23, 2025 31.06M sh
Shares Diluted FY 2025 · Jun 30, 2025 31.17M sh
Shares Diluted FY 2025 · Jun 30, 2024 30.87M sh
Capex FY 2025 · Jun 30, 2025 $191K
Capex FY 2025 · Jun 30, 2024 $553K
Operating Cash Flow FY 2025 · Jun 30, 2025 $2.07M
Operating Cash Flow FY 2025 · Jun 30, 2024 $943K
Cash And Equivalents FY 2025 · Jun 30, 2025 $3.62M
Cash And Equivalents FY 2025 · Jun 30, 2024 $1.68M
Stockholders Equity FY 2025 · Jun 30, 2025 $20.32M
Stockholders Equity FY 2025 · Jun 30, 2024 $19.24M
Stockholders Equity FY 2025 · Jun 30, 2023 $18.86M
Current Liabilities FY 2025 · Jun 30, 2025 $4.25M
Current Liabilities FY 2025 · Jun 30, 2024 $6.12M
Total Liabilities FY 2025 · Jun 30, 2025 $4.58M
Total Liabilities FY 2025 · Jun 30, 2024 $6.97M
Current Assets FY 2025 · Jun 30, 2025 $18.76M
Current Assets FY 2025 · Jun 30, 2024 $17.88M
Total Assets FY 2025 · Jun 30, 2025 $24.9M
Total Assets FY 2025 · Jun 30, 2024 $26.21M
Eps Diluted FY 2025 · Jun 30, 2025 $0.03
Eps Diluted FY 2025 · Jun 30, 2024 $0.00
Eps Basic FY 2025 · Jun 30, 2025 $0.03
Eps Basic FY 2025 · Jun 30, 2024 $0.00
Sga Expense FY 2025 · Jun 30, 2025 $3.54M
Sga Expense FY 2025 · Jun 30, 2024 $3.63M
Net Income FY 2025 · Jun 30, 2025 $808K
Net Income FY 2025 · Jun 30, 2024 $112K
Operating Income FY 2025 · Jun 30, 2025 $2.02M
Operating Income FY 2025 · Jun 30, 2024 $251K
Gross Profit FY 2025 · Jun 30, 2025 $5.56M
Gross Profit FY 2025 · Jun 30, 2024 $3.88M
Cost Of Revenue FY 2025 · Jun 30, 2025 $48.79M
Cost Of Revenue FY 2025 · Jun 30, 2024 $46.43M